These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 15529387

  • 1. Passive transfer of Sjogren's syndrome IgG produces the pathophysiology of overactive bladder.
    Wang F, Jackson MW, Maughan V, Cavill D, Smith AJ, Waterman SA, Gordon TP.
    Arthritis Rheum; 2004 Nov; 50(11):3637-45. PubMed ID: 15529387
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antiidiotypic antibodies neutralize autoantibodies that inhibit cholinergic neurotransmission.
    Cavill D, Waterman SA, Gordon TP.
    Arthritis Rheum; 2003 Dec; 48(12):3597-602. PubMed ID: 14674012
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Antimuscarinic antibodies in primary Sjögren's syndrome reversibly inhibit the mechanism of fluid secretion by human submandibular salivary acinar cells.
    Dawson LJ, Stanbury J, Venn N, Hasdimir B, Rogers SN, Smith PM.
    Arthritis Rheum; 2006 Apr; 54(4):1165-73. PubMed ID: 16572451
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Evidence that anti-muscarinic antibodies in Sjögren's syndrome recognise both M3R and M1R.
    Schegg V, Vogel M, Didichenko S, Stadler MB, Beleznay Z, Gadola S, Sengupta C, Stadler BM, Miescher SM.
    Biologicals; 2008 Jul; 36(4):213-22. PubMed ID: 18249005
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Antibodies interfering with the type 3 muscarinic receptor pathway inhibit gastrointestinal motility and cholinergic neurotransmission in Sjögren's syndrome.
    Park K, Haberberger RV, Gordon TP, Jackson MW.
    Arthritis Rheum; 2011 May; 63(5):1426-34. PubMed ID: 21312189
    [Abstract] [Full Text] [Related]

  • 14. Effect of anti-muscarinic autoantibodies on leukocyte function in Sjögren's syndrome.
    Namkoong E, Lee SW, Kim N, Choi Y, Park K.
    Mol Immunol; 2017 Oct; 90():136-142. PubMed ID: 28750255
    [Abstract] [Full Text] [Related]

  • 15. Muscarinic receptor function, density and G-protein coupling in the overactive diabetic rat bladder.
    Stevens LA, Sellers DJ, McKay NG, Chapple CR, Chess-Williams R.
    Auton Autacoid Pharmacol; 2006 Jul; 26(3):303-9. PubMed ID: 16879496
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Electroporation-mediated muscarinic M3 receptor gene transfer into rat urinary bladder.
    Otani M, Yoshida M, Iwashita H, Kawano Y, Miyamae K, Inadome A, Nishi T, Ueda S.
    Int J Urol; 2004 Nov; 11(11):1001-8. PubMed ID: 15509205
    [Abstract] [Full Text] [Related]

  • 18. Autoantibodies in primary Sjögren's syndrome patients induce internalization of muscarinic type 3 receptors.
    Jin M, Hwang SM, Davies AJ, Shin Y, Bae JS, Lee JH, Lee EB, Song YW, Park K.
    Biochim Biophys Acta; 2012 Feb; 1822(2):161-7. PubMed ID: 22137887
    [Abstract] [Full Text] [Related]

  • 19. Cholinergic activation of phasic activity in the isolated bladder: possible evidence for M3- and M2-dependent components of a motor/sensory system.
    Finney SM, Stewart LH, Gillespie JI.
    BJU Int; 2007 Sep; 100(3):668-78. PubMed ID: 17627783
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.